- 6/7/2019BLU-5937: A Highly Selective P2X3 Homotrimeric Receptor Antagonist, Exhibits Excellent Pharmacokinetic and Safety Profile Including Improved Taste Safety Profile in Healthy Subjects. 2019 American Cough Conference.
En Savoir Plus - 5/21/2019BLU-5937 a Highly Selective P2X3 Homotrimeric Receptor Antagonist with Improved Taste Safety Profile in Healthy Subjects. 2019 American Thoracic Society Conference.
En Savoir Plus - 3/20/2019BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration. ELSEVIER.
En Savoir Plus
Science
Publications scientifiques